Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentre, Open-label Trial Evaluating the Pharmacokinetics of NovoEight® (Turoctocog Alfa) in Relation to BMI in Subjects With Haemophilia A

NCT02941354 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT02941354
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02941354 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentre, Open-label Trial Evaluating the Pharmacokinetics of NovoEight® (Turoctocog Alfa) in Relation to BMI in Subjects With Haemophilia A
Lead sponsor
Novo Nordisk A/S
Phase
Phase 1
Overall status
Completed
Start date
October 10, 2016
Completion date
June 20, 2017
Enrollment
35 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

congenital bleeding disorder, haemophilia a